Smartphone app aims to help cancer patients kick the habit

NCT ID NCT04409236

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This phase 3 trial tests a smartphone app called Quit2Heal designed to help cancer patients stop smoking. 427 participants will use either Quit2Heal or a standard quit-smoking app. The goal is to see if the specialized app leads to more people quitting for at least 30 days after 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Quit2Heal smartphone application

What this could lead to

If it works, this could provide an effective, accessible tool to help cancer patients quit smoking, improving their overall health and treatment outcomes.

What could go wrong

This is a behavioral intervention, so results may vary widely. The app may not work for everyone, and long-term quit rates could be modest.

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.